Advertisement
Advertisement
U.S. Markets close in 3 hrs 26 mins
Advertisement
Advertisement
Advertisement
Advertisement

The Oncology Institute, Inc. (TOIIW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.12000.0000 (0.00%)
As of 10:08AM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    The Oncology Institute Expands Into Chino, CA

    Practice of Dr. Labib Hashimi Adds Another TOI California LocationCERRITOS, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, has acquired the Chino, CA practice of Dr. Labib Hashimi. The acquisition enhances TOI’s geographic coverage in California, with the Chino practice marking TOI’s 42nd clinic in the Golden State. “We are excited to expand to Chino and Chino Hills, increasing a

  • GlobeNewswire

    The Oncology Institute Rebrands Clinical Trials Division

    Innovative Clinical Research Institute Will Become TOI Clinical ResearchCERRITOS, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, is rebranding its clinical research division. Previously, TOI’s clinical research division was named Innovative Clinical Research Institute (ICRI). The division’s new name is TOI Clinical Research. TOI Clinical Research will carry on the important work

  • GlobeNewswire

    The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa

    TOI continues expansion in South FloridaCERRITOS, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced its entrance into Miami-Dade County, Florida with the acquisition of Hematology/Oncology Associates of Miami and the addition of a Senior Medical Director for Florida, further strengthening their investment in South Florida. Dr. Roberto Ochoa, former National Director, Hemat

Advertisement
Advertisement